X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-04-10 | XTNT | Orbimed Advisors LLC | 10% | S - Sale | $0.42 | -73,114,592 | 0 | -100% | -$30,708,129 | ||||||
2023-11-17 | XTNT | Brandt Kevin D | Chief Commercial Officer | P - Purchase | $1.20 | +41,670 | 815,860 | +5% | +$49,837 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |